We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Ares Capital
ARCC
$14.4B
| $323K | ﹤0.01% |
17,265
-133
| -0.8% | -$2.39K |
|
2677
Consolidated Water Co
CWCO
$488M
| $323K | ﹤0.01% |
24,000
-750
| -3% | -$10K |
|
2678
Lexicon Pharmaceuticals
LXRX
$1.1B
| $323K | ﹤0.01% |
55,078
-1,611
| -3% | -$11.2K |
|
|
BRT
2679
BRT Apartments
BRT
$271M
| $321K | ﹤0.01% |
19,055
-520
| -3% | -$8.48K |
|
2680
Investar Holding Corp
ISTR
$414M
| $321K | ﹤0.01% |
15,626
-590
| -4% | -$11.1K |
|
2681
Organogenesis Holdings
ORGO
$239M
| $321K | ﹤0.01% |
17,644
+3,556
| +25% | +$48.2K |
|
|
IHC
2682
DELISTED
Independence Holding Company
IHC
| $319K | ﹤0.01% |
8,007
-220
| -3% | -$8.97K |
|
2683
Village Super Market
VLGEA
$639M
| $318K | ﹤0.01% |
13,509
-510
| -4% | -$11.8K |
|
2684
Evolus
EOLS
$501M
| $317K | ﹤0.01% |
24,379
-710
| -3% | -$6.54K |
|
2685
LCNB Corp
LCNB
$283M
| $317K | ﹤0.01% |
18,113
-740
| -4% | -$12.4K |
|
|
HMTV
2686
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $317K | ﹤0.01% |
27,238
-1,100
| -4% | -$12.6K |
|
2687
First Bank
FRBA
$454M
| $316K | ﹤0.01% |
25,940
-900
| -3% | -$9.73K |
|
|
SUMO
2688
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $315K | ﹤0.01% |
16,692
+4,520
| +37% | +$132K |
|
2689
Parke Bancorp
PKBK
$405M
| $314K | ﹤0.01% |
15,710
-580
| -4% | -$11K |
|
2690
Cartesian Therapeutics
RNAC
$268M
| $314K | ﹤0.01% |
2,311
-56
| -2% | -$6.95K |
|
|
AXDX
2691
DELISTED
Accelerate Diagnostics
AXDX
| $309K | ﹤0.01% |
3,720
-177
| -5% | -$18K |
|
2692
Northeast Bank
NBN
$1.14B
| $308K | ﹤0.01% |
11,677
-330
| -3% | -$8.85K |
|
|
ESXB
2693
DELISTED
Community Bankers Trust Corporation
ESXB
| $304K | ﹤0.01% |
34,477
-1,190
| -3% | -$9.23K |
|
2694
Oil-Dri
ODC
$1.34B
| $301K | ﹤0.01% |
17,466
| – | – |
|
|
NESR
2695
National Energy Services Reunited Corp
NESR
$2.93B
| $301K | ﹤0.01% |
24,305
-670
| -3% | -$7.88K |
|
|
CODX
2696
Co-Diagnostics
CODX
$5.6M
| $300K | ﹤0.01% |
1,047
-69
| -6% | -$27.5K |
|
|
APLT
2697
DELISTED
Applied Therapeutics
APLT
| $295K | ﹤0.01% |
15,742
-160
| -1% | -$3.45K |
|
2698
Grid Dynamics Holdings
GDYN
$615M
| $295K | ﹤0.01% |
18,518
-720
| -4% | -$10.3K |
|
2699
Lakeland Industries
LAKE
$119M
| $295K | ﹤0.01% |
10,598
-770
| -7% | -$23.9K |
|
2700
Nathan's Famous
NATH
$402M
| $295K | ﹤0.01% |
4,683
-150
| -3% | -$9.27K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.